{"product_id":"cdk1-antibody-cdc2-bha17104234","title":"CDK1 Antibody \/ CDC2","description":"\u003ch2\u003eOverview\u003c\/h2\u003e \u003cp\u003eCDK1 antibody supplied as a antigen affinity purified reagent for WB in Human samples. This product is a polyclonal (rabbit origin) antibody (host: Rabbit; isotype: Rabbit IgG) intended for research use only.\u003c\/p\u003e \u003ch2\u003eKey elements and design rationale\u003c\/h2\u003e \u003cul\u003e   \u003cli\u003e\n\u003cstrong\u003eAntibody identity:\u003c\/strong\u003e Polyclonal (rabbit origin); host Rabbit; isotype Rabbit IgG.\u003c\/li\u003e   \u003cli\u003e\n\u003cstrong\u003eFormat and purification:\u003c\/strong\u003e format: Antigen affinity purified; purity: Antigen affinity.\u003c\/li\u003e   \u003cli\u003e\n\u003cstrong\u003eSpecies reactivity (reported):\u003c\/strong\u003e Human.\u003c\/li\u003e   \u003cli\u003e\n\u003cstrong\u003eApplications (listed):\u003c\/strong\u003e WB.\u003c\/li\u003e   \u003cli\u003e\n\u003cstrong\u003eImmunogen \/ epitope context:\u003c\/strong\u003e An amino acid sequence from the C-terminus of human CDK1 (KMALNHPYFNDLDNQIKKM) was used as the immunogen for this CDK1 antibody..\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003eThese attributes help you align the antibody with the biological question (target state, sample type, and readout) while keeping interpretation grounded in appropriate controls.\u003c\/p\u003e \u003ch2\u003eBiological background\u003c\/h2\u003e \u003cp\u003eCDK1 is the intended antigen for this primary antibody. Reported biological context includes: Cyclin-dependent Kinase 1, also called Cell Division Cycle 2, or CDC2, is a catalytic subunit of a protein kinase complex called the M-phase promoting factor that induces entry into mitosis and is universal among eukaryotes. In HeLa cells,\u003ca href=\"..\/search_result.php?search_txt=cdk1\"\u003eCdk1\u003c\/a\u003eis the most abundant phosphotyrosine-containing protein and its phosphotyrosine content is subject to cell cycle regulation.\u003c\/p\u003e \u003ch2\u003eResearch relevance and current trends\u003c\/h2\u003e \u003cul\u003e   \u003cli\u003ePost-translational modification mapping: phosphorylation-site–resolved antibodies are used to connect signaling inputs to target activation states and downstream readouts.\u003c\/li\u003e   \u003cli\u003eSignal-flow and turnover studies: researchers pair immunodetection with perturbations that modulate enzymatic activity or proteostasis to understand regulation, stability, and feedback.\u003c\/li\u003e   \u003cli\u003eSpatial and single-cell approaches: imaging-based and cytometry workflows increasingly quantify heterogeneity and relocalization rather than only bulk abundance.\u003c\/li\u003e \u003c\/ul\u003e \u003ch2\u003eCommon research applications\u003c\/h2\u003e \u003cul\u003e   \u003cli\u003eWestern blot (WB): compare relative abundance\/isoform patterns across conditions and sample types; band shifts may reflect processing or post-translational modification.\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003eAcross these readouts, differences in signal intensity, localization, or complex enrichment are typically interpreted alongside sample-matched controls and independent evidence to distinguish regulation from technical variation.\u003c\/p\u003e \u003ch2\u003eNotes for experimental interpretation\u003c\/h2\u003e \u003cul\u003e   \u003cli\u003eIsoforms, cleavage products, or post-translational modifications can alter apparent molecular weight and subcellular distribution; interpret bands and staining patterns in the context of expected biology and sample preparation.\u003c\/li\u003e   \u003cli\u003eSpecies differences and epitope conservation may affect binding; use matched positive controls and orthogonal evidence when comparing across organisms.\u003c\/li\u003e   \u003cli\u003eControl concepts: include appropriate isotype and secondary-only controls (for imaging), and consider genetic perturbations (knockout\/knockdown\/overexpression) or independent antibodies targeting distinct epitopes to strengthen conclusions.\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003eEpitope context is defined by the immunogen description; when available, align this with known domains, PTM sites, or family homology to anticipate potential cross-reactivity patterns. As a polyclonal antibody, recognition spans multiple epitopes, which can improve detection across conformations but may broaden background depending on sample context.\u003c\/p\u003e \u003c!-- Sources (internal): - UniProtKB entry (P06493) — UniProt Consortium — https:\/\/www.uniprot.org\/uniprotkb\/P06493\/entry - NCBI Gene search (CDK1) — NCBI — https:\/\/www.ncbi.nlm.nih.gov\/gene\/?term=CDK1 - Ensembl search (CDK1) — Ensembl — https:\/\/www.ensembl.org\/Multi\/Search\/Results?q=CDK1 - PubMed search (CDK1) — NLM — https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=CDK1 - Reactome pathway search (CDK1) — Reactome — https:\/\/reactome.org\/content\/query?q=CDK1 --\u003e","brand":"NSJ Bioreagents","offers":[{"title":"0.5mg\/ml if reconstituted with 0.2ml sterile DI water \/ 100 ug","offer_id":53043263635821,"sku":"R30620","price":449.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/get_image_597d8600-d7c2-47e1-b04a-e0b8a4fb0207.jpg?v=1771934536","url":"https:\/\/www.ebiohippo.com\/products\/cdk1-antibody-cdc2-bha17104234","provider":"BioHippo","version":"1.0","type":"link"}